FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Decode Genetics related Press Releases

deCODE genetics, Together with Academic Collaborators and Illumina, Discovers Genetic Risk Factor for Skin, Prostate and Brain C

Posted September 25, 2011

REYKJAVIK, Iceland, September 25, 2011 /PRNewswire/ -- Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain, Denmark, Germany, Sweden, the USA, the UK and Read more...

deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma

Posted September 13, 2010

REYKJAVIK, Iceland, September 13, 2010 /PRNewswire-FirstCall/ -- - SNP on Chromosome 7 is Rare Among Chinese but Confers Five-Fold Increase in Risk; Underscores Importance of Analyzing Risk Factors Read more...

Announcing the New deCODE

Posted January 22, 2010

Reykjavik, ICELAND, January 21, 2010 - deCODE genetics ehf today emerged as a newly financed, private company focused on advancing the science of human genetics and its application to products and

Read more...

deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention

Posted February 6, 2009

deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention REYKJAVIK, Iceland, Feb. 6 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: Read more...

deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis

Posted December 16, 2008

deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis REYKJAVIK, Iceland, December 15 deCODE REYKJAVIK, Iceland, December 15

Read more...

Major deCODE-led Study Underscores Role of the Brain in Obesity

Posted December 14, 2008

REYKJAVIK, Iceland, December 14 /PRNewswire-FirstCall/ -- In one of the largest studies of its kind, a multinational team led by scientists from deCODE genetics (Nasdaq:DCGN) today report the Read more...

Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack

Posted January 9, 2008

Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack Reykjavik, ICELAND, January 9, 2008 – deCODE genetics (Nasdaq:DCGN) today announced Read more...

deCODE Launches deCODEme(TM)

Posted November 16, 2007

Name: 
PR Newswire
REYKJAVIK, Iceland, Nov. 16 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODEme(TM), a pioneering service that enables individuals to get a detailed look Read more...